Exact Mass: 390.1477
Exact Mass Matches: 390.1477
Found 302 metabolites which its exact mass value is equals to given mass value 390.1477
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Loganin
Loganin is an iridoid monoterpenoid with formula C17H26O10 that is isolated from several plant species and exhibits neuroprotective and anti-inflammatory properties. It has a role as a plant metabolite, a neuroprotective agent, an EC 3.4.23.46 (memapsin 2) inhibitor, an EC 3.2.1.20 (alpha-glucosidase) inhibitor, an anti-inflammatory agent and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a cyclopentapyran, a beta-D-glucoside, an enoate ester, a monosaccharide derivative, an iridoid monoterpenoid, a methyl ester and a secondary alcohol. It is functionally related to a loganetin. Loganin is one of the best-known of the iridoid glycosides. It is named for the Loganiaceae, having first been isolated from the seeds of a member of that plant family, namely those of Strychnos nux-vomica. It also occurs in Alstonia boonei (Apocynaceae),[1] a medicinal tree of West Africa and in the medicinal/entheogenic shrub Desfontainia spinosa (Columelliaceae) native to Central America and South America. Loganin is a natural product found in Strychnos axillaris, Lonicera japonica, and other organisms with data available. An iridoid monoterpenoid with formula C17H26O10 that is isolated from several plant species and exhibits neuroprotective and anti-inflammatory properties. Loganin, also known as loganoside, is a member of the class of compounds known as iridoid o-glycosides. Iridoid o-glycosides are iridoid monoterpenes containing a glycosyl (usually a pyranosyl) moiety linked to the iridoid skeleton. Thus, loganin is considered to be an isoprenoid lipid molecule. Loganin is soluble (in water) and a very weakly acidic compound (based on its pKa). Loganin can be found in a number of food items such as groundcherry, annual wild rice, muscadine grape, and broad bean, which makes loganin a potential biomarker for the consumption of these food products. Loganin is one of the best-known of the iridoid glycosides.It is named for the Loganiaceae,having first been isolated from the seeds of a member of that plant family, namely those of Strychnos nux-vomica. It also occurs in Alstonia boonei (Apocynaceae), a medicinal tree of West Africa and in the medicinal/entheogenic shrub Desfontainia spinosa (Columelliaceae) native to Central America and South America . Loganin is formed from loganic acid by the enzyme loganic acid O-methyltransferase (LAMT). Loganin then becomes a substrate for the enzyme secologanin synthase (SLS) to form secologanin, a secoiridoid monoterpene found as part of ipecac and terpene indole alkaloids. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects.
Todatriol glucoside
Todatriol glucoside is a constituent of the fruit of Carum ajowan (ajowan). Constituent of the fruit of Carum ajowan (ajowan)
Mesuagin
Constituent of seeds of Mammea americana (mamey). Mesuagin is found in fruits and mammee apple. Mesuagin is found in fruits. Mesuagin is a constituent of seeds of Mammea americana (mamey)
Loganoside
Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects.
Epitalon
Regadenoson
6-Butyryl-5-hydroxy-4-phenylseselin
2-(glycer-2-yl)-5-(2-hydroxyethyl)phenyl-O-beta-D-glucopyranoside
7-methoxy-1-methyl-9H-beta-carbolin-8-yl beta-D-glucopyranoside|Ruine
4-O-methylguaiacyl glycerol 2-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 2-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 8-O-beta-glucopyranoside
(1R,2R)-4-O-Methylguaiacyl glycerol 3-O-??-D-glucopyranoside|(1R,2R)-4-O-methylguaiacylglycerol 3-O-beta-D-glucopyranoside|(1R,2R)-O-methylguaiacyl glycerol 3-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 9-O-beta-glucopyranoside
3-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)propyl beta-D-glucopyranoside|juniperoside XI
3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)propyl beta-D-glucopyranoside|juniperoside X
2,4,6-trihydroxy-3-(4-hydroxycinnamyl)dihydrochalcone|balsacone C
(1R*,4aS*,5R*,7R*,7aR*)-1-<(beta-D-glucopyranosyl)oxy>-1,4a,5,6,7,7a-hexahydro-7-hydroxy-7methylcyclopentapyran-6-yl acetate|(1R*,4aS*,5R*,7R*,7aR*)-1-[(beta-D-glucopyranosyl)oxy]-1,4a,5,6,7,7a-hexahydro-7-hydroxy-7methylcyclopenta[c]pyran-6-yl acetate
5-hydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-h]chromen-2-one
C17H26O10_2H-Pyran-5-carboxylic acid, 3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-4-(2-hydroxyethyl)-, methyl ester, (2S,3R,4S)
methyl (1S)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate
5-hydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-h]chromen-2-one [IIN-based: Match]
methyl (1S)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate_major
Ala Ala Asp Asp
Ala Cys Pro Thr
Ala Cys Thr Pro
Ala Asp Ala Asp
Ala Asp Asp Ala
Ala Asp Glu Gly
Ala Asp Gly Glu
Ala Glu Asp Gly
Ala Glu Gly Asp
Ala Gly Asp Glu
Ala Gly Glu Asp
Ala Pro Cys Thr
Ala Pro Thr Cys
Ala Thr Cys Pro
Ala Thr Pro Cys
Cys Ala Pro Thr
Cys Ala Thr Pro
Cys Pro Ala Thr
Cys Pro Thr Ala
Cys Thr Ala Pro
Cys Thr Pro Ala
Asp Ala Ala Asp
Asp Ala Asp Ala
Asp Ala Glu Gly
Asp Ala Gly Glu
Asp Asp Ala Ala
Asp Glu Ala Gly
Asp Glu Gly Ala
Asp Gly Ala Glu
Asp Gly Glu Ala
Glu Ala Asp Gly
Glu Ala Gly Asp
Glu Asp Ala Gly
Glu Asp Gly Ala
Glu Glu Gly Gly
Glu Gly Ala Asp
Glu Gly Asp Ala
Glu Gly Glu Gly
Glu Gly Gly Glu
Gly Ala Asp Glu
Gly Ala Glu Asp
Gly Asp Ala Glu
Gly Asp Glu Ala
Gly Glu Ala Asp
Gly Glu Asp Ala
Gly Glu Glu Gly
Gly Glu Gly Glu
Gly Gly Glu Glu
Gly Met Pro Ser
Gly Met Ser Pro
Gly Asn Asn Ser
Gly Asn Ser Asn
Gly Pro Met Ser
Gly Pro Ser Met
Gly Ser Met Pro
Gly Ser Asn Asn
Gly Ser Pro Met
Met Gly Pro Ser
Met Gly Ser Pro
Met Pro Gly Ser
Met Pro Ser Gly
Met Ser Gly Pro
Met Ser Pro Gly
Asn Gly Asn Ser
Asn Gly Ser Asn
Asn Asn Gly Ser
Asn Asn Ser Gly
Asn Ser Gly Asn
Asn Ser Asn Gly
Pro Ala Cys Thr
Pro Ala Thr Cys
Pro Cys Ala Thr
Pro Cys Thr Ala
Pro Gly Met Ser
Pro Gly Ser Met
Pro Met Gly Ser
Pro Met Ser Gly
Pro Ser Gly Met
Pro Ser Met Gly
Pro Thr Ala Cys
Pro Thr Cys Ala
Ser Gly Met Pro
Ser Gly Asn Asn
Ser Gly Pro Met
Ser Met Gly Pro
Ser Met Pro Gly
Ser Asn Gly Asn
Ser Asn Asn Gly
Ser Pro Gly Met
Ser Pro Met Gly
Thr Ala Cys Pro
Thr Ala Pro Cys
Thr Cys Ala Pro
Thr Cys Pro Ala
Thr Pro Ala Cys
Thr Pro Cys Ala
Chidamide
Todatriol glucoside
Methyl (1S)-1-(?-D-glucopyranosyloxy)-7-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
Methyl (1S)-1-(?-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
ethyl 3-oxo-4-(triphenylphosphoranylidene)butyrate
RS 102895 hydrochloride
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Sultopride hydrochloride
Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
Regadenoson
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2]. Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2].
ALPHA,ALPHA-DI-TERT-BUTYL-ALPHA,ALPHA-DICYANO-2,3,5,6-TETRAFLUORO-1,4-BENZENEDIACETONITRILE
Valganciclovir Hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Valganciclovir hydrochloride is an orally active antiviral agent. Valganciclovir hydrochloride can inhibit the growth of adenoviruses and have a protective effect on immunosuppressed hamsters. Valganciclovir hydrochloride can be used for the research of Cytomegalovirus[1][2][3].
1-{[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl}piperazine dihydrochloride
Epithalon
Epitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].
(2R)-2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl valinate hydrochloride (1:1)
Tucidinostat
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
5-chloro-2-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)-N-(6-(3-methoxybenzamido)pyridin-3-yl)isonicotinamide
N-acetyldemethylphosphinothricyl-L-alanyl-L-leucine
Sodium prasterone sulfate
Dehydroepiandrosterone sulfate sodium salt (DHEAS) is the most abundant circulating steroid in human. Dehydroepiandrosterone sulfate sodium salt (DHEAS) affects steroid hormone biosynthesis on a molecular level resulting in an increased formation of pregnenolone[1].
Glu-Gly-Trp
A tripeptide composed of L-glutamic acid, glycine and L-tryptophan joined in sequence by peptide linkages.
Trp-Ala-Asp
A tripeptide composed of L-tryptophan, L-alanine, and L-aspartic acid joined by a peptide linkage.
Ala-Ala-Asp-Asp
A tetrapeptide composed of two L-alanine units linked to two L-aspartic acid units by peptide linkages.
1-(2,3-dihydroindol-1-yl)-2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]ethanone
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
(4R)-4-[(2R,3R,5R,6S)-3-hydroxy-5-(1H-indole-3-carbonyloxy)-6-methyloxan-2-yl]oxypentanoate
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
(4-fluorophenyl)-[(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
(6Z)-6-[[4-(diethylamino)phenyl]methylidene]-3-(2-methylphenyl)-[1,3]thiazolo[2,3-c][1,2,4]triazol-5-one
sodium dehydroepiandrosterone sulfate
An organic sodium salt that is the monosodium salt of dehydroepiandrosterone sulfate.
MARK4 inhibitor 1
MARK4 inhibitor 1 is a potent and selective microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis[1].
RSK4-IN-1
RSK4-IN-1 is a potent RSK4 inhibitor with a IC50 value of 9.5 nM. RSK4-IN-1 has antitumor activity[1].
(2r,3r,4s,5s,6r)-2-{[(1r,2s)-1-(3,4-dimethoxyphenyl)-1,3-dihydroxypropan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,4ar,7s,7as)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl (1s,4as,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1r,4as,7s,7as)-7-hydroxy-7-methyl-1-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1s,4as,6s,7r,7as)-6-hydroxy-7-methyl-1-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1r,4ar,7r,7ar)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
2-({6-hydroxy-4-[hydroxy(methoxy)methyl]-7-methylidene-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,4as,7s,7as)-4a-hydroxy-7-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl (1s,4ar,5s,7s,7ar)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
(1s,4ar,7s,7as)-4a-hydroxy-7-methyl-1-{[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl 6-hydroxy-7-methyl-1-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1s,4as,5s,7s,7ar)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1s,4ar,5s,7r,7ar)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1s,4as,5r,7r,7ar)-5-hydroxy-7-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl acetate
1'-(3-hydroxy-4,5-dimethoxyphenyl)-propane-2',3'-diol 3'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN001242","Ingredient_name": "1'-(3-hydroxy-4,5-dimethoxyphenyl)-propane-2',3'-diol 3'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C17H26O10","Ingredient_Smile": "COC1=CC(=CC(=C1OC)O)CC(COC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10038","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-beta-glucogeniposide
{"Ingredient_id": "HBIN002397","Ingredient_name": "1-beta-glucogeniposide","Alias": "NA","Ingredient_formula": "C17H26O10","Ingredient_Smile": "COC(=O)C1COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25699","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1'r,2'r)-4-o-methylguaiacyl glycerol 3'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003046","Ingredient_name": "(1'r,2'r)-4-o-methylguaiacyl glycerol 3'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C17H26O10","Ingredient_Smile": "COC1=C(C=C(C=C1)C(C(COC2C(C(C(C(O2)CO)O)O)O)O)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14468","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] ethanoate
{"Ingredient_id": "HBIN003257","Ingredient_name": "[(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] ethanoate","Alias": "[(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] acetate; acetic acid [(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] ester; [(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] acetate; acetic acid [(1S,4aR,5S,7S,7aS)-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] ester","Ingredient_formula": "C17H26O10","Ingredient_Smile": "NA","Ingredient_weight": "390.38","OB_score": "6.594198254","CAS_id": "52916-96-8","SymMap_id": "SMIT10213","TCMID_id": "NA","TCMSP_id": "MOL009020","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-Dihydroverbenalin
{"Ingredient_id": "HBIN007370","Ingredient_name": "3,4-Dihydroverbenalin","Alias": "2-[7-methyl-5-oxo-1-[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,6,7,7a-hexahydro-1H-cyclopenta[c]pyran-4-yl]acetic acid; 3,4-dihydroverbenalin; AC1NSULZ","Ingredient_formula": "C17H26O10","Ingredient_Smile": "CC1CC(=O)C2C1C(OCC2CC(=O)O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "390.43","OB_score": "10.81682989","CAS_id": "NA","SymMap_id": "SMIT01197","TCMID_id": "5734","TCMSP_id": "MOL008758","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-acetylajugol
{"Ingredient_id": "HBIN012592","Ingredient_name": "6-o-acetylajugol","Alias": "NA","Ingredient_formula": "C17H26O10","Ingredient_Smile": "CC(=O)OC1CC(C2C1C=COC2OC3C(C(C(C(O3)CO)O)O)O)(C)O","Ingredient_weight": "390.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "308","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10596537","DrugBank_id": "NA"}
7-epi-Loganin
{"Ingredient_id": "HBIN013178","Ingredient_name": "7-epi-Loganin","Alias": "7-epi-loganin","Ingredient_formula": "C17H26O10","Ingredient_Smile": "CC1C(CC2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "390.4 g/mol","OB_score": "4.777690361","CAS_id": "NA","SymMap_id": "SMIT05233","TCMID_id": "28116","TCMSP_id": "MOL003099","TCM_ID_id": "NA","PubChem_id": "71676045","DrugBank_id": "NA"}
8-epiloganin
{"Ingredient_id": "HBIN013722","Ingredient_name": "8-epiloganin","Alias": "8-epi-loganin","Ingredient_formula": "C17H26O10","Ingredient_Smile": "CC1C(CC2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "390.4 g/mol","OB_score": "11.68476547","CAS_id": "NA","SymMap_id": "SMIT05207","TCMID_id": "6952;30219","TCMSP_id": "MOL003073","TCM_ID_id": "NA","PubChem_id": "10548420","DrugBank_id": "NA"}
Ajugoside_qt
{"Ingredient_id": "HBIN014998","Ingredient_name": "Ajugoside_qt","Alias": "ajugoside_qt","Ingredient_formula": "C17H26O10","Ingredient_Smile": "NA","Ingredient_weight": "390.38","OB_score": "81.68080326","CAS_id": "52916-96-8","SymMap_id": "SMIT05724","TCMID_id": "NA","TCMSP_id": "MOL003692;MOL009021;MOL012317","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}